Table 3

Procedural safety and short-term outcome of percutaneous LAA occlusion

ReferencePatients (n)Successful implantation (%)Pericardial effusion (%)Device embolisation (%)Bail-out surgery (%)Stroke/ embolism (%)Major bleeding (%)Death
PLAATO
 Sievert et al75151006.700000
 Hanna et al7611100000000
 Ostermayer et al77111974.600.900.9
 El-Chami et al781110000000
 De Meester (2008)791090011.1000
 Ussia et al8020905.600000
 Park et al81731001.41.41.41.41.4
 Block et al8264981.61.61.6
 Bayard et al83180903.30.61.11.1
 Viles-Gonzalez et al64221004.50000
Watchman
 Sick et al8466883.031.501.50
 Holmes et al55463 (PAF)884.80.61.90.20
 Reddy et al60460 (CAP)952.200.200.70
 Kim et al855100000000
 Swaans et al8610100010.00010.00
 Bai et al87581001.700000
 Swaans et al883010003.30000
 Reddy et al56150951.31.300
ACP
 Park et al89137963.61.52.200
 Lam et al90209500000
 Montenegro et al915100000000
 Danna et al9237922.95.9000
 López-Mínguez et al723597000000
 Helsen et al93151000006.700
 Nietlispach et al94*152962.64.63.32.00
 Freixa et al3342100000000
 Urena et al9552981.91.9003.80
 Streb et al9621954.800000
 Meerkin et al971001001.000000
 Faustino et al982196000000
 Plicht et al57341002.90005.90
 Apostolos et al62969971.20.20.71.20.6
  • *Nietlispach et al94: non-dedicated LAA occlusion devices were used in 32 patients, dedicated (ACP) in 120 patients.

  • ACP, Amplatzer cardiac plugs; LAA, left atrial appendage.